The CPHI Pharma Index – a collateralised metric of all small molecule categories – reported its second highest ever total, just 2.5% down on the 2022 all-time high. This result highlights the medium-term trajectory of the industry and the underlying strength of market fundamentals. The Index was released in full at CPHI Barcelona in October 2023.
Reducing environmental impact and decreasing costs are powerful incentives for innovators to focus on, turning potentially hazardous chemical waste into something useful. Increasingly, that also includes looking to industrial waste for chemicals that may be useful to the pharmaceutical industry.
The road to Net Zero is a long and winding one for industry, requiring many long-term changes and significant shifts in everything from more green energy production to zero-emission vehicles, and from more efficient manufacturing to reformulating products using more environmentally friendly raw materials.